# Double-Blind Naltrexone in Kleptomania

> **NCT00332579** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 25 (actual)

## Conditions studied

- Kleptomania

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00332579
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-01
- **Primary completion:** 2008-09-01
- **Final completion:** 2008-09-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332579, "Double-Blind Naltrexone in Kleptomania". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00332579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*